InvestorsHub Logo
Followers 16
Posts 1317
Boards Moderated 0
Alias Born 07/21/2013

Re: Doktornolittle post# 93668

Tuesday, 02/28/2017 11:01:08 AM

Tuesday, February 28, 2017 11:01:08 AM

Post# of 468407
Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson’s disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010.[1]
In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News